CONMED Corporation (CNMD) - Total Assets
Based on the latest financial reports, CONMED Corporation (CNMD) holds total assets worth $2.31 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CONMED Corporation - Total Assets Trend (1986–2025)
This chart illustrates how CONMED Corporation's total assets have evolved over time, based on quarterly financial data. Also see CNMD market cap overview for the company's overall valuation and market capitalisation.
CONMED Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
CONMED Corporation's total assets of $2.31 Billion consist of 28.9% current assets and 71.1% non-current assets. Review CONMED Corporation (CNMD) financial obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.8% |
| Accounts Receivable | $247.83 Million | 10.7% |
| Inventory | $355.54 Million | 15.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $582.05 Million | 25.0% |
| Goodwill | $807.01 Million | 34.7% |
Asset Composition Trend (1986–2025)
This chart illustrates how CONMED Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of CONMED Corporation for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CONMED Corporation's current assets represent 28.9% of total assets in 2025, a decrease from 60.9% in 1986.
- Cash Position: Cash and equivalents constituted 1.8% of total assets in 2025, down from 4.7% in 1986.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 59.0% of total assets, an increase from 0.0% in 1986.
- Asset Diversification: The largest asset category is goodwill at 34.7% of total assets.
CONMED Corporation Competitors by Total Assets
Key competitors of CONMED Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medtronic plc
SA:MDTC34
|
Brazil | R$93.03 Billion |
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Medartis Holding AG
SW:MED
|
Switzerland | CHF610.05 Million |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
|
China | CN¥3.54 Billion |
|
PULSION Medical Systems SE
MU:PUS
|
Germany | €35.15 Million |
CONMED Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.29 | 2.26 | 2.23 |
| Quick Ratio | 1.04 | 1.00 | 1.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $377.88 Million | $355.85 Million | $244.72 Million |
CONMED Corporation - Advanced Valuation Insights
This section examines the relationship between CONMED Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.09 |
| Latest Market Cap to Assets Ratio | 0.47 |
| Asset Growth Rate (YoY) | 0.8% |
| Total Assets | $2.33 Billion |
| Market Capitalization | $1.08 Billion USD |
Valuation Analysis
Below Book Valuation: The market values CONMED Corporation's assets below their book value (0.47x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: CONMED Corporation's assets grew by 0.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for CONMED Corporation (1986–2025)
The table below shows the annual total assets of CONMED Corporation from 1986 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $2.33 Billion | +0.85% |
| 2024-12-31 | $2.31 Billion | +0.27% |
| 2023-12-31 | $2.30 Billion | +0.11% |
| 2022-12-31 | $2.30 Billion | +30.10% |
| 2021-12-31 | $1.77 Billion | +0.82% |
| 2020-12-31 | $1.75 Billion | -1.32% |
| 2019-12-31 | $1.78 Billion | +29.65% |
| 2018-12-31 | $1.37 Billion | +0.82% |
| 2017-12-31 | $1.36 Billion | +2.18% |
| 2016-12-31 | $1.33 Billion | +19.41% |
| 2015-12-31 | $1.11 Billion | +1.34% |
| 2014-12-31 | $1.10 Billion | +0.70% |
| 2013-12-31 | $1.09 Billion | +0.56% |
| 2012-12-31 | $1.08 Billion | +15.91% |
| 2011-12-31 | $935.59 Million | -5.09% |
| 2010-12-31 | $985.77 Million | +2.95% |
| 2009-12-31 | $957.50 Million | +2.77% |
| 2008-12-31 | $931.66 Million | +4.22% |
| 2007-12-31 | $893.95 Million | +3.76% |
| 2006-12-31 | $861.57 Million | -4.67% |
| 2005-12-31 | $903.78 Million | +3.55% |
| 2004-12-31 | $872.83 Million | +8.42% |
| 2003-12-31 | $805.06 Million | +8.48% |
| 2002-12-31 | $742.14 Million | +5.78% |
| 2001-12-31 | $701.61 Million | +3.24% |
| 2000-12-31 | $679.57 Million | +2.62% |
| 1999-12-31 | $662.20 Million | +5.31% |
| 1998-12-31 | $628.80 Million | +11.97% |
| 1997-12-31 | $561.60 Million | +230.16% |
| 1996-12-31 | $170.10 Million | +42.46% |
| 1995-12-31 | $119.40 Million | +92.27% |
| 1994-12-31 | $62.10 Million | +8.38% |
| 1993-12-31 | $57.30 Million | +36.75% |
| 1992-12-31 | $41.90 Million | +9.40% |
| 1991-12-31 | $38.30 Million | +72.52% |
| 1990-12-31 | $22.20 Million | +1.37% |
| 1989-12-31 | $21.90 Million | +62.22% |
| 1988-12-31 | $13.50 Million | +3.85% |
| 1987-12-31 | $13.00 Million | +103.13% |
| 1986-12-31 | $6.40 Million | -- |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation an… Read more